Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (Dehydroxymethylepoxyquinomicin) in medulloblastoma cell lines

• Grant number: 10/18792-2
• Support Opportunities: Scholarships in Brazil - Doctorate
• Start date: March 01, 2011
• End date: March 31, 2014
• Field of knowledge: Biological Sciences - Genetics - Human and Medical Genetics
• Principal Investigator: Luiz Gonzaga Tone
• Grantee: Priscila Maria Manzini Ramos
• Host Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

RAMOS, PRISCILA M. M.; PEZUK, JULIA A.; CASTRO-GAMERO, ANGEL M.; OLIVEIRA, HARLEY F.; SCRIDELI, CARLOS A.; UMEZAWA, KAZUO; TONE, LUIZ G.. Antineoplastic Effects of NF-kappa B Inhibition by DHMEQ (Dehydroxymethylepoxyquinomicin) Alone and in Co-treatment with Radio-and Chemotherapy in Medulloblastoma Cell Lines. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, v. 18, n. 4, p. 541-549, 2018. (10/18792-2, 11/01026-8)

Academic Publications

(References retrieved automatically from State of São Paulo Research Institutions)

RAMOS, Priscila Maria Manzini. Evaluation of anti-neoplastic effects of NF-kB inhibition by DHMEQ (Dehidroximetilepoxiquinomicina) in medulloblastoma cell lines. 2014. Doctoral Thesis - Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (PCARP/BC) Ribeirão Preto.